However, always tell us what medications you're currently taking so we can make sure there are no interactions
This requires two codes: E11.22 Diabetes with CKD N18.x CKD stage N18.1N18.9 (Stage 15 or unspecified) N18.6 for ESRD Important Documentation Notes The provider must specify both diabetes and CKD or state a relationship (diabetic CKD, diabetes with CKD, etc.)
This expectation sets up inevitable disappointment
GLP-1s still account for a relatively small share of the total number of Medicaid prescriptions, accounting for about 1% of all Medicaid prescriptions in 2024 (up from about 0% in 2019)
Ending obesity coverage for GLP-1 obesity drugs could improve the states finances but might also result in health inequities and less comprehensive coverage, the states health and human services agency acknowledged in its September budget request
Youre not alone in this and it often does get better with the right adjustments